EM44 SELF MONITORING BLOOD GLUCOSE SYSTEM, EM44 PRO SELF MONITORING BLOOD GLUCOSE SYSTEM

Glucose Dehydrogenase, Glucose

EPS BIO TECHNOLOGY CORP.

The following data is part of a premarket notification filed by Eps Bio Technology Corp. with the FDA for Em44 Self Monitoring Blood Glucose System, Em44 Pro Self Monitoring Blood Glucose System.

Pre-market Notification Details

Device IDK112272
510k NumberK112272
Device Name:EM44 SELF MONITORING BLOOD GLUCOSE SYSTEM, EM44 PRO SELF MONITORING BLOOD GLUCOSE SYSTEM
ClassificationGlucose Dehydrogenase, Glucose
Applicant EPS BIO TECHNOLOGY CORP. NO.8 R&D RD III HSINCHU SCIENCE PARK Hsinchu City, Hsinchu,  TW 30077
ContactYc Lei
CorrespondentYc Lei
EPS BIO TECHNOLOGY CORP. NO.8 R&D RD III HSINCHU SCIENCE PARK Hsinchu City, Hsinchu,  TW 30077
Product CodeLFR  
Subsequent Product CodeJJX
Subsequent Product CodeNBW
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2011-08-08
Decision Date2011-09-07

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
01885017000170 K112272 000
00885017000447 K112272 000
10885017000635 K112272 000
00885017000584 K112272 000
10885017000567 K112272 000
00885017000416 K112272 000
00885017000362 K112272 000
10885017000284 K112272 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.